OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F3929 for the delivery of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068. This award is issued as a delivery order under the parent contract SPE2DX25D9900 and was posted on DIBBS on July 21, 2026, with an award date of March 30, 2026. The total contract value is detailed in the award documentation and the item is procured for federal use by the Department of Defense. The awardee, identified by CAGE code 1UNB0, is the sole supplier for this specific pharmaceutical item under this procurement action, though no set-aside designation or NAICS code is specified. The place of performance and point of contact information are not provided, and the contract is administered through the DLA’s electronic award system with a public link for reference.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
